Ignite Creation Date:
2025-12-25 @ 4:36 AM
Ignite Modification Date:
2026-05-18 @ 2:37 PM
Study NCT ID:
NCT01059318
Status:
COMPLETED
Last Update Posted:
2020-11-19
First Post:
2010-01-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis
Sponsor:
Novartis Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CRAD001X2201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None